Avantax Advisory Services Inc. Trims Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

Avantax Advisory Services Inc. lowered its stake in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 5.7% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 2,344 shares of the company’s stock after selling 141 shares during the period. Avantax Advisory Services Inc.’s holdings in Addus HomeCare were worth $294,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in ADUS. Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Addus HomeCare during the third quarter worth $1,622,000. JPMorgan Chase & Co. lifted its stake in Addus HomeCare by 10.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 183,198 shares of the company’s stock worth $24,371,000 after acquiring an additional 16,997 shares in the last quarter. Principal Financial Group Inc. boosted its holdings in Addus HomeCare by 17.5% during the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock valued at $67,293,000 after acquiring an additional 75,409 shares during the period. Cherry Creek Investment Advisors Inc. acquired a new position in Addus HomeCare in the 4th quarter valued at about $340,000. Finally, Barclays PLC increased its stake in Addus HomeCare by 204.8% during the third quarter. Barclays PLC now owns 43,470 shares of the company’s stock worth $5,783,000 after purchasing an additional 29,207 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Trading Up 4.4 %

Shares of ADUS opened at $95.01 on Wednesday. The firm has a market cap of $1.73 billion, a PE ratio of 21.74, a price-to-earnings-growth ratio of 1.41 and a beta of 0.97. Addus HomeCare Co. has a 12-month low of $87.88 and a 12-month high of $136.72. The company’s 50 day simple moving average is $110.45 and its 200-day simple moving average is $121.26.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing the consensus estimate of $1.35 by ($0.09). The business had revenue of $297.14 million for the quarter, compared to analyst estimates of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. As a group, equities research analysts forecast that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Insiders Place Their Bets

In other Addus HomeCare news, CEO R Dirk Allison sold 25,000 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the transaction, the chief executive officer now owns 79,397 shares in the company, valued at approximately $9,905,569.72. The trade was a 23.95 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 4.60% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several research firms have recently commented on ADUS. Citizens Jmp raised shares of Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. StockNews.com downgraded Addus HomeCare from a “buy” rating to a “hold” rating in a report on Wednesday, February 26th. Macquarie reissued an “outperform” rating and issued a $129.00 price objective on shares of Addus HomeCare in a research report on Thursday, February 27th. Oppenheimer lifted their price objective on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Finally, Stephens reissued an “overweight” rating and issued a $142.00 target price on shares of Addus HomeCare in a report on Wednesday, March 12th. One research analyst has rated the stock with a sell rating, one has given a hold rating, seven have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $132.78.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.